JESSE J. GEIGER - 27 Oct 2025 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
President
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Jesse J. Geiger
Issuer symbol
MEDP
Transactions as of
27 Oct 2025
Transactions value $
-$10,023,457
Form type
4
Filing time
29 Oct 2025, 17:12:31 UTC
Previous filing
28 Jul 2025
Next filing
07 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GEIGER JESSE J President C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI /s/ Stephen P. Ewald, Attorney-in-Fact for Jesse J. Geiger 29 Oct 2025 0001677399

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Options Exercise $3.24M +19.5K +53.31% $166.73 56K 27 Oct 2025 Direct
transaction MEDP Common Stock Sale -$11.8M -19.5K -34.77% $605.12 36.5K 27 Oct 2025 Direct F1, F2
transaction MEDP Common Stock Options Exercise $595K +3.57K +9.77% $166.73 40.1K 29 Oct 2025 Direct
transaction MEDP Common Stock Sale -$2.09M -3.57K -8.9% $585.00 36.5K 29 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEDP Employee Stock Option (Right to Buy) Options Exercise $0 -19.5K -84.51% $0.00 3.57K 27 Oct 2025 Common Stock 19.5K $166.73 Direct F3
transaction MEDP Employee Stock Option (Right to Buy) Options Exercise $0 -3.57K -100% $0.00 0 29 Oct 2025 Common Stock 3.57K $166.73 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.00 to $610.66. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3 The option vested in full on October 27, 2025.